Back to
JENNISON ASSOCIATES LLC
FATE
Showing 0 of 13 quarters
Position history for
JENNISON ASSOCIATES LLC's holdings in FATE THERAPEUTICS INC
No. Jennison Associates exited its FATE (Fate Therapeutics) position in Q4 2021. Its Q3 2021 13F listed 383,714 shares worth $22.7M. Jennison Associates already held FATE in its Q4 2018 13F, the earliest on record, and held it in 12 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.